Chemoinformaics analysis of 4-PROPAN-2-YLCYCLOHEX-3-ENE-1-CARBALDEHYDE
| Molecular Weight | 152.237 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 26 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -4.832 | nHRing | 0 |
| Solubility: LogP | 6.362 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.424 |
| Synth | 4.91 |
| Natural Product Likeliness | 2.971 |
| NR-PPAR-gamma | 0.103 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0 |
| HIA | 0.019 |
| CACO-2 | -4.98 |
| MDCK | 0.00000781 |
| BBB | 0.766 |
| PPB | 0.976163 |
| VDSS | 1.309 |
| FU | 0.0236454 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.94 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.311 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.425 |
| CYP3a4-inh | 0.242 |
| CYP3a4-sub | 0.258 |
| CL | 10.052 |
| T12 | 0.015 |
| hERG | 0.002 |
| Ames | 0.017 |
| ROA | 0.058 |
| SkinSen | 0.014 |
| Carcinogencity | 0.018 |
| EI | 0.718 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.873 |
| Antiviral | No |
| Prediction | 0.929863 |